Adverse Liver Outcomes, Cardiovascular Events, and Mortality in Steatotic Liver Disease
This cohort study found that patients with MetALD and ALD had modestly higher risks of adverse liver outcomes and all-cause mortality than those with MASLD, with similar risks of MACE. Alcohol and fibrosis assessments may help identify patients at increased risk for long-term adverse outcomes.
Authors
- Rebecca A. Hubbard (ORCID: https://orcid.org/0000-0003-0879-0994)
- Marina Serper (ORCID: https://orcid.org/0000-0003-4899-2160)
- Pedro Ochoa‐Allemant (ORCID: https://orcid.org/0000-0002-7826-655X)
- David Kaplan (ORCID: https://orcid.org/0000-0003-0294-549X)
Institutions
- Brown University (US)
- Philadelphia VA Medical Center (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- JAMA Internal Medicine
- Published
- 2025-06-16
- DOI
- https://doi.org/10.1001/jamainternmed.2025.1809
- Citations
- 18
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 24.38